India’s Bioeconomy to Reach $300 Billion by 2030; Government Launches BRCP Phase-III to Strengthen Biomedical Research

Why is it in News ?

The Government of India has launched Phase-III of the Biomedical Research Career Programme (BRCP) with an investment of ₹1,500 crore. During the launch, the government also highlighted India's rapidly growing bioeconomy, which has expanded from USD 10 billion in 2014 to over USD 195 billion in 2025 and is expected to reach USD 300 billion by 2030.

Why is it in News ?

The Government of India has launched Phase-III of the Biomedical Research Career Programme (BRCP) with an investment of ₹1,500 crore. During the launch, the government also highlighted India's rapidly growing bioeconomy, which has expanded from USD 10 billion in 2014 to over USD 195 billion in 2025 and is expected to reach USD 300 billion by 2030.

What is Bioeconomy ?

A bioeconomy refers to an economy that uses biological resources, biotechnology, and life sciences to produce sustainable products, healthcare solutions, industrial materials, food, energy, and environmental technologies.

It combines sectors such as :

• Biotechnology
• Pharmaceuticals
• Agriculture
• Healthcare
• Bio-manufacturing
• Biofuels
• Industrial biotechnology
• Environmental biotechnology

The objective is to promote sustainable economic growth while reducing dependence on fossil resources.

India's Bioeconomy Growth

Major Reasons Behind the Growth

• Rapid expansion of biotechnology startups
• Strong government support through DBT and BIRAC
• Growth of vaccine manufacturing
• Increase in biomedical research
• Expansion of bio-manufacturing
• Public-private partnerships
• Startup ecosystem under Startup India

India hosts around 12,000 biotechnology startups, making it one of the fastest-growing biotechnology ecosystems globally.

What is BRCP (Biomedical Research Career Programme) ?

The Biomedical Research Career Programme (BRCP) is a flagship initiative launched in 2008 by the Department of Biotechnology (DBT) in collaboration with the Wellcome Trust, UK.

Its objective is to support talented biomedical researchers throughout different stages of their scientific careers.

The programme provides :

• Research Fellowships
• Research Grants
• International Collaboration
• Leadership Development
• Career Support for Biomedical Scientists

BRCP Phase-III: Key Highlights

Total Financial Outlay

• ₹1,500 crore

Funding Pattern

• ₹1,000 crore – Department of Biotechnology (Government of India)
• ₹500 crore – Wellcome Trust (United Kingdom)

Duration

Phase-III will provide long-term support for biomedical research and fellowships.

Objectives of BRCP Phase-III

The programme aims to :

• Develop globally competitive biomedical researchers
• Support basic scientists
• Promote clinician-scientists
• Encourage public health research
• Strengthen science communication
• Develop research managers
• Promote interdisciplinary research
• Encourage international collaboration
• Improve healthcare innovation
• Support translational research

Achievements of BRCP Since 2008

Over the past 18 years, BRCP has :

• Supported 500+ researchers
• Strengthened research in 200+ institutions
• Trained thousands of students
• Produced internationally recognized biomedical research
• Improved India's scientific reputation globally

Why is Biotechnology Important ?

According to Dr. Jitendra Singh, biotechnology will drive the next industrial revolution because it contributes to :

India's Biotechnology Ecosystem

India has become one of the world's leading biotechnology destinations due to :

• Around 12,000 biotech startups
• Global vaccine manufacturing capacity
• Strong pharmaceutical industry
• Skilled scientific workforce
• Government support through :
  • Department of Biotechnology (DBT)
  • BIRAC
  • National Biopharma Mission
  • BioE3 Policy
• Increasing international collaborations

What is Wellcome Trust ?

The Wellcome Trust is one of the world's largest charitable foundations dedicated to :

• Biomedical research
• Public health
• Medical innovation
• Global health partnerships

It has been collaborating with India's Department of Biotechnology since 2008.

Significance for India

The initiative will help India :

• Become a global biotechnology hub
• Strengthen scientific innovation
• Generate high-skilled employment
• Improve healthcare technologies
• Promote affordable diagnostics
• Increase global competitiveness
• Build a knowledge-based economy
• Support the vision of Viksit Bharat 2047

Challenges Ahead

• Need for higher private sector investment
• Brain drain of talented researchers
• Limited research infrastructure in some institutions
• High cost of advanced biotechnology
• Regulatory hurdles
• Need for stronger academia-industry collaboration

Way Forward

• Increase investment in R&D
• Strengthen university-industry partnerships
• Promote translational research
• Encourage global collaborations
• Expand startup funding
• Build advanced biotechnology infrastructure
• Improve commercialization of research

Conclusion

India's biotechnology sector is entering a transformative phase. With the launch of BRCP Phase-III and sustained government investment, the country aims to build a world-class biomedical research ecosystem while expanding its bioeconomy to USD 300 billion by 2030. The initiative is expected to enhance scientific innovation, strengthen healthcare research, promote biotechnology startups, and position India as a leading global biotechnology hub.